Patients in Bind as Brain Cancer Drug Price Rises to $1,000 Per Pill
Company's decision means there is one less option in a limited number of approved chemotherapies
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.